Anti-VEGF Treatment for Prevention of PDR/DME
Condition(s):Diabetic Retinopathy; Diabetic Macular EdemaLast Updated:June 18, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Diabetic Retinopathy; Diabetic Macular EdemaLast Updated:June 18, 2023Completed
Condition(s):Kidney Injury; Proteinuria; HypertensionLast Updated:August 3, 2022Terminated
Condition(s):Choroidal Neovascularization; Punctate Inner ChoroidopathyLast Updated:January 8, 2019Completed
Condition(s):Retinopathy of PrematurityLast Updated:November 26, 2007Completed
Condition(s):Obstructive Sleep ApneaLast Updated:January 27, 2021Completed
Condition(s):Diabetic Macular EdemaLast Updated:January 16, 2024Recruiting
Condition(s):Refractory Angina Pectoris; Gene Transfer; Coronary Artery DiseaseLast Updated:December 5, 2023Active, not recruiting
Condition(s):Age-Related Macular DegenerationLast Updated:April 9, 2012Completed
Condition(s):Differentiated Thyroid CancerLast Updated:March 22, 2024Active, not recruiting
Condition(s):Acute Coronary SyndromeLast Updated:May 27, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.